Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1992 2
1994 1
1995 2
1996 2
1997 2
1998 1
1999 5
2001 3
2002 6
2003 3
2004 10
2005 6
2006 4
2007 2
2008 3
2009 3
2010 3
2011 6
2012 4
2013 2
2014 1
2015 7
2016 6
2017 8
2018 8
2019 7
2020 3
2021 6
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28076247

119 results

Results by year

Filters applied: . Clear all
Page 1
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.
Connolly LE, Riddle V, Cebrik D, Armstrong ES, Miller LG. Connolly LE, et al. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01989-17. doi: 10.1128/AAC.01989-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29378708 Free PMC article. Clinical Trial.
Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.
Wagenlehner F, Nowicki M, Bentley C, Lückermann M, Wohlert S, Fischer C, Vente A, Naber K, Dalhoff A. Wagenlehner F, et al. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02317-17. doi: 10.1128/AAC.02317-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29339395 Free PMC article. Clinical Trial.
Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D. Naber KG, et al. Int J Antimicrob Agents. 2004 Jun;23(6):596-605. doi: 10.1016/j.ijantimicag.2003.12.017. Int J Antimicrob Agents. 2004. PMID: 15194131 Clinical Trial.
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.
Ren H, Li X, Ni ZH, Niu JY, Cao B, Xu J, Cheng H, Tu XW, Ren AM, Hu Y, Xing CY, Liu YH, Li YF, Cen J, Zhou R, Xu XD, Qiu XH, Chen N. Ren H, et al. Int Urol Nephrol. 2017 Mar;49(3):499-507. doi: 10.1007/s11255-017-1507-0. Epub 2017 Jan 20. Int Urol Nephrol. 2017. PMID: 28108978 Free PMC article. Clinical Trial.
119 results